DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.nature.com/articles/nm.2938, but it redirected us to https://www.nature.com/articles/nm.2938. The analysis below is for the second page.

Title[redir]:
The tumor microenvironment controls drug sensitivity | Nature Medicine
Description:
A better understanding of mechanisms involved in regulation of drug sensitivity is crucial for improved cancer treatment. New studies show that cells of the tumor microenvironment modulate the response of cancer cells to chemotherapy and targeted therapies through production of secreted factors ( pages 1359–1368 ).

Matching Content Categories {📚}

Telecommunications
Science
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, nature, cancer, google, scholar, cas, access, content, cells, cell, med, cookies, open, privacy, microenvironment, östman, data, medicine, tumor, arne, therapy, res, nat, author, advertising, information, subscribe, september, drug, sensitivity, institution, articles, tumour, gastric, scientific, buy, engl, clin, permissions, research, optional, media, personal, parties, policy, journals, log, journal, news, views,

Topics {✒️}

nature portfolio 3d micro-organisation printing mir-3619-5p/ampk/pgc1α/cebpb axis permissions reprints privacy policy macrophages jia-bin wang advertising content treatment-induced damage nature 487 nature social media tumor microenvironment modulate springerlink instant access personal data author correspondence author declares data protection permissions breast cancer res drug sensitivity improved cancer treatment privacy competing financial interests explore content subscription content access gastric cancer european economic area victoria sarne … klas institutional subscriptions read cancer cell 21 accepting optional cookies article östman journals search log arne östman manage preferences cancer cells chemo-resistance content issue learn cancer res article purchase cancer biol cell res article cite 07 september 2012 institution buy optional cookies choices essential cookies

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The tumor microenvironment controls drug sensitivity
         description:A better understanding of mechanisms involved in regulation of drug sensitivity is crucial for improved cancer treatment. New studies show that cells of the tumor microenvironment modulate the response of cancer cells to chemotherapy and targeted therapies through production of secreted factors ( pages 1359â1368 ).
         datePublished:2012-09-07T00:00:00Z
         dateModified:2012-09-07T00:00:00Z
         pageStart:1332
         pageEnd:1334
         sameAs:https://doi.org/10.1038/nm.2938
         keywords:
            Cancer microenvironment
            Cancer therapy
            Pharmacokinetics
            Biomedicine
            general
            Cancer Research
            Metabolic Diseases
            Infectious Diseases
            Molecular Medicine
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnm.2938/MediaObjects/41591_2012_Article_BFnm2938_Fig1_HTML.jpg
         isPartOf:
            name:Nature Medicine
            issn:
               1546-170X
               1078-8956
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Arne Ãstman
               affiliation:
                     name:Karolinska Institutet, Stockholm, Sweden.
                     address:
                        name:Arne Ãstman is in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.,
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The tumor microenvironment controls drug sensitivity
      description:A better understanding of mechanisms involved in regulation of drug sensitivity is crucial for improved cancer treatment. New studies show that cells of the tumor microenvironment modulate the response of cancer cells to chemotherapy and targeted therapies through production of secreted factors ( pages 1359â1368 ).
      datePublished:2012-09-07T00:00:00Z
      dateModified:2012-09-07T00:00:00Z
      pageStart:1332
      pageEnd:1334
      sameAs:https://doi.org/10.1038/nm.2938
      keywords:
         Cancer microenvironment
         Cancer therapy
         Pharmacokinetics
         Biomedicine
         general
         Cancer Research
         Metabolic Diseases
         Infectious Diseases
         Molecular Medicine
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnm.2938/MediaObjects/41591_2012_Article_BFnm2938_Fig1_HTML.jpg
      isPartOf:
         name:Nature Medicine
         issn:
            1546-170X
            1078-8956
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Arne Ãstman
            affiliation:
                  name:Karolinska Institutet, Stockholm, Sweden.
                  address:
                     name:Arne Ãstman is in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.,
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Medicine
      issn:
         1546-170X
         1078-8956
      volumeNumber:18
Organization:
      name:Nature Publishing Group US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Karolinska Institutet, Stockholm, Sweden.
      address:
         name:Arne Ãstman is in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Arne Ãstman
      affiliation:
            name:Karolinska Institutet, Stockholm, Sweden.
            address:
               name:Arne Ãstman is in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.,
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Arne Ãstman is in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(2)

External Links {🔗}(136)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.33s.